Theragenics Corporation Confirms Rejection of Takeover Proposal from German Company

Theragenics Corporation TGX today confirmed that its Board of Directors has rejected a takeover proposal from Eckert & Ziegler Strahlen- und Medizintechnik AG of Berlin, either directly or through its subsidiary IBt Bebig, saying it significantly undervalues the company.

The proposal from EUZ and its wholly owned subsidiary, IBt, would allow EUZ to acquire all outstanding shares of Theragenics' stock at $2.20 per share.